BlueCrest Capital Management Ltd bought a new stake in Aetna Inc. (NYSE:AET) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 2,797 shares of the company’s stock, valued at approximately $425,000.
Several other institutional investors also recently modified their holdings of the company. Peapack Gladstone Financial Corp acquired a new stake in shares of Aetna in the 2nd quarter valued at about $216,000. Janus Henderson Group PLC raised its stake in shares of Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares in the last quarter. San Francisco Sentry Investment Group CA raised its stake in shares of Aetna by 10.4% in the 2nd quarter. San Francisco Sentry Investment Group CA now owns 2,290 shares of the company’s stock valued at $347,000 after purchasing an additional 216 shares in the last quarter. Signet Financial Management LLC raised its stake in shares of Aetna by 0.5% in the 2nd quarter. Signet Financial Management LLC now owns 57,286 shares of the company’s stock valued at $8,697,000 after purchasing an additional 275 shares in the last quarter. Finally, Shelton Capital Management acquired a new stake in shares of Aetna in the 2nd quarter valued at about $733,000. Institutional investors and hedge funds own 89.65% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “BlueCrest Capital Management Ltd Takes $425,000 Position in Aetna Inc. (AET)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/27/bluecrest-capital-management-ltd-acquires-shares-of-2797-aetna-inc-aet.html.
A number of equities research analysts have recently issued reports on AET shares. BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective on the stock in a research note on Tuesday, July 4th. Argus reiterated a “buy” rating and set a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Cantor Fitzgerald reiterated a “buy” rating and set a $175.00 price objective on shares of Aetna in a research note on Monday. Finally, Deutsche Bank AG increased their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Nine research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $162.36.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares in the company, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.
Shares of Aetna Inc. (NYSE:AET) traded down 0.07% during mid-day trading on Friday, reaching $178.47. 2,717,749 shares of the company were exchanged. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $180.57. The stock has a market capitalization of $59.27 billion, a P/E ratio of 39.62 and a beta of 0.53. The firm has a 50-day moving average price of $158.42 and a 200 day moving average price of $150.77.
Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s revenue was down 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 EPS. Equities research analysts anticipate that Aetna Inc. will post $9.48 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend is Wednesday, October 11th. Aetna’s dividend payout ratio is 43.67%.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.